Institute for Myeloma and Bone Cancer Research

The Institute for Myeloma and Bone Cancer Research is an independent, non-profit cancer research institute dedicated to finding a cure for multiple myeloma, a plasma cell cancer found in bone marrow. More than 100,000 people are diagnosed with myeloma every year and it is estimated that more than 1,000,000 are living with myeloma worldwide. IMBCR was founded in 2004 by leading myeloma researcher and oncologist, Dr. James R. Berenson whose research in both the clinic and the laboratory has spanned more than 25 years. Research conducted at IMBCR has created many of the novel-therapeutics used for myeloma patients worldwide.

Contact information:

Los Angeles , CA


Continued Progress in Multiple Myeloma Research: An Update with Dr. James Berenson

Watch Dr. James Berenson’s overview of progress in multiple myeloma research and treatment from ASCO 2014


Is Treating Myeloma A Marathon or a Sprint?

Dr. James Berenson, from the Institute for Myeloma & Bone Cancer Research, discusses the importance of weighing risks and benefits when choosing a myeloma treatment path.


ASCO Myeloma Update: More Promising Medicines on the Way

Dr. James Berenson gives his perspective on the latest drug development updates from ASCO 2012


Update on the Drug Development Pipeline for Myeloma

Dr. James Berenson covers data presented at the end of 2011 for various agents in trials for myeloma.


The Latest in Myeloma


Ask Dr. Berenson: Updates on Myeloma Treatment and Bone Health (August 2011)

Watch Dr. James Berenson as he updates us on a wide range of myeloma treatment options, research and treatment.

Myeloma Update from ASCO

Dr. James Berenson gives a positive update for Myeloma patients on new drugs, clinical trials, with an emphasis on quality-of-life.

Join Our Community Register for Events Read Our Latest Blog

Page last updated on April 22, 2014